Neumora Corp (NMRA): Operating Profitability

Brandmark of Neumora Therapeutics, Inc. (NMRA)

Neumora Therapeutics brings together leading neurobiologists and data scientists, investing in large-scale R&D. The EBIT margin reflects efficiency dynamics, with the metric currently at 0.00. The company is currently conducting clinical trials independently while forming technological alliances with scientific institutes. Financial success is based on the development of precision medicines for the treatment of schizophrenia and depression, which will later be procured by government systems.

NMRA: Neumora Therapeutics, Inc. Operating Margin 02/21/2024 - 11/20/2026

Metric breakdowns and analytics for Neumora Therapeutics, Inc. (NMRA)

- share price and consensus valuation forecast:
Basic company analysis:Neumora Therapeutics, Inc.
Finished products of neumoratx.com

Fundamental analysis of this asset requires risk minimization through an assessment of operational process efficiency. For Neumora Therapeutics (NMRA), which develops patent-protected drugs for brain pathologies, the ability to generate internal cash flow is critical. Operating profit margin demonstrates the share of profit from core activities before accounting for financial expenses and taxes. This indicator measures the real efficiency of the business model without the influence of debt load, and its trend determines capital stability over the long term.

Direct competitors

Operating Sales Margin BIIB|NBIX: Operating Profit Rate|Operating Profitability Regencell Bioscience Ltd (RGC)|Operating Margin axsome.com (AXSM)|Operating Margin ACAD (acadia-pharm.com)|XENE - Operating Sales Margin|vikingtherapeutics.com - Operating Margin|Supernus Pharma (SUPN) - Operating Sales Margin|CPRX: Operating Margin|Denali Therapeutics Inc. (DNLI) - Operating Margin|Operating Profitability Harmony Pharma|Operating Profitability BHVN|Operating Sales Margin AMLX (Amylyx Pharmaceuticals, Inc.)|Operating Sales Margin Trevi Corp TRVI|Operating Profitability praxismedicines.com PRAX|AVXL - Operating Sales Margin|CeriBell EEG - Operating Margin|Operating Return on Sales prothena.com|Alector Therapeutics (ALEC) - Operating Profitability|Annexon Biosciences Inc. - Operating Profit Rate|OMER (Omeros Corp) - Operating Margin|Operating Margin neurogene.com|Operating Margin ACIU|VYGR - Operating Return on Sales|Operating Profitability Scilex Holding Company, Inc. SCLX|Operating Profitability Margin Tevogen Bio Inc.|ACOG - Operating Profitability|Operating Profitability Margin Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Operating Sales Margin|Cassava Sciences Inc (SAVA) - Operating Margin|Operating Sales Margin ASRT|Operating Margin coyatherapeutics.com|Operating Margin VTGN|Ovid Therapeutics - Return on Sales by Operating Profit|Operating Margin ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Operating Sales Margin|ATHE - Operating Profitability|Profitability of Operations clene.com CLNN|PEPG: Operating Margin|Return on Sales by Operating Profit JUNS|RLMD (Relmada Corp) - Operating Margin|Annovis Bio Inc (ANVS) - Profitability of Operations|Operating Profitability Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Operating Profit Rate|Operating Profitability Klotho Neurosciences KLTO|NRSN: Return on Sales by Operating Profit|RVPH: Operating Sales Margin|MTVA: Operating Profitability|NRXS (NeurAxis Inc) - Operating Sales Margin|Operating Sales Margin Helius Medical Technologies, Inc.|Operating Profitability Passage Bio Inc.|Operating Return on Sales bionomics.com.au NEUP|Operating Margin NERV|Operating Margin Athira Pharma Inc (ATHA)|Operating Margin ADXN (Addex Therapeutics Ltd.)|ALZN: Return on Sales by Operating Profit|CYCN - Operating Profitability|Operating Return on Sales Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Operating Sales Margin|Operating Profitability Margin Cortigent, Inc. CRGT|Operating Profitability Avenue Therapeutics, Inc.|Operating Sales Margin BrainStorm Cell Therapeutics Inc. (BCLI)|Operating Profitability Cara Therapeutics, Inc (CARA)|Operating Profitability CHRO (Chromocell Therapeutics Corp.)|Operating Margin ELYM (eliemtx.com)|intracellulartherapies.com - Operating Profitability|LBPH: Operating Sales Margin|Operating Profit Rate MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Operating Sales Margin|Operating Sales Margin NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Operating Margin|Neurotrope - Operating Profit Margin|Operating Margin TRVN|Profitability of Operations Vigil Neuroscience, Inc.|Operating Profitability Anew Medical, Inc. WENA|CERE - Operating Sales Margin